Jee Woong Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jee Woong Choi has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
- Jin Cheol Kim
Department of Dermatology, Ajou University School of Medicine, Suwon, Korea
7 shared publications - Bark-Lynn Lew
Department of Dermatology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea
6 shared publications - Chang-Hun Huh
Department of Dermatology Seoul National University Bundang Hospital Seongnam Korea
6 shared publications - Min Sung Kim
Department of Dermatology, Chosun University College of Medicine, Gwangju, Korea
6 shared publications - Yong Hyun Jang
Department of Dermatology, School of Medicine, Kyungpook National University, Daegu, Korea
6 shared publications You Chan Kim
Department of Dermatology, Ajou University School of Medicine, Suwon-si, Republic of Korea
6 shared publications
Latest Publications
- 18 September 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (11)
Shared founder effect of the LIPH variant underlies the high prevalence of autosomal recessive woolly hair/hypotrichosis in Korea and Japan
- 18 September 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (11)
Shared founder effect of the LIPH variant underlies the high prevalence of autosomal recessive woolly hair/hypotrichosis in Korea and Japan
- 23 July 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (12) , 1622-1633
Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real‐world chart review in South Korea
Alopecia areata (AA) is a clinically heterogeneous, immune‐mediated, non‐scarring hair loss disorder. This real‐world chart review sought to characterize treatment patterns and healthcare resource use among patients with severe AA in South Korea. A web‐based chart review of 40 dermatologists was conducted in which the medical charts of 151 adult patients diagnosed with severe AA between May 2019 and April 2021 were reviewed. Anonymized data on patient characteristics, treatment patterns, healthcare resource use, and clinical outcomes were extracted from the date of severe disease diagnosis until the date of data collection (September–November 2022). Sixty‐six percent of patients were diagnosed with severe disease at initial presentation, while 34% were re‐classed to severe during the disease course. Mean estimated patient age at the time of diagnosis of severe AA was 37.1 (range 22–68) years. Fifty‐three percent of patients were male. Most patients (93.4%) received pharmacological treatment for their condition; 45.5% received ≥2 lines of treatment with a mean duration of 24 months. First‐line treatment discontinuation due to lack of efficacy occurred in 46.0% of cases. Hair regrowth occurred in 71.0% of patients, 59.2% of whom experienced major regrowth (≥60%) during the follow‐up period. Median (95% confidence interval) time to regrowth was 13.7 (11.0–20.6) months. Treatment visit rates per person‐year ranged from two (phototherapy) to 10 (topical treatment), dermatologist visits occurred at a rate of 12.9 per person‐year and 6.0% of patients were hospitalized due to alopecia areata. The majority of hospitalizations were related to treatment and occurred in patients who received pulse systemic corticosteroid therapy. The patient and economic burden of AA in South Korea is high and there remains a critical unmet need among patients with severe AA with respect to the effectiveness of commonly used treatment strategies.
- 23 July 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (12) , 1622-1633
Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real‐world chart review in South Korea
Alopecia areata (AA) is a clinically heterogeneous, immune‐mediated, non‐scarring hair loss disorder. This real‐world chart review sought to characterize treatment patterns and healthcare resource use among patients with severe AA in South Korea. A web‐based chart review of 40 dermatologists was conducted in which the medical charts of 151 adult patients diagnosed with severe AA between May 2019 and April 2021 were reviewed. Anonymized data on patient characteristics, treatment patterns, healthcare resource use, and clinical outcomes were extracted from the date of severe disease diagnosis until the date of data collection (September–November 2022). Sixty‐six percent of patients were diagnosed with severe disease at initial presentation, while 34% were re‐classed to severe during the disease course. Mean estimated patient age at the time of diagnosis of severe AA was 37.1 (range 22–68) years. Fifty‐three percent of patients were male. Most patients (93.4%) received pharmacological treatment for their condition; 45.5% received ≥2 lines of treatment with a mean duration of 24 months. First‐line treatment discontinuation due to lack of efficacy occurred in 46.0% of cases. Hair regrowth occurred in 71.0% of patients, 59.2% of whom experienced major regrowth (≥60%) during the follow‐up period. Median (95% confidence interval) time to regrowth was 13.7 (11.0–20.6) months. Treatment visit rates per person‐year ranged from two (phototherapy) to 10 (topical treatment), dermatologist visits occurred at a rate of 12.9 per person‐year and 6.0% of patients were hospitalized due to alopecia areata. The majority of hospitalizations were related to treatment and occurred in patients who received pulse systemic corticosteroid therapy. The patient and economic burden of AA in South Korea is high and there remains a critical unmet need among patients with severe AA with respect to the effectiveness of commonly used treatment strategies.
- Open Access
- 27 June 2024
- Published by S. Karger AG in Dermatology
- Vol. 240 (5-6) , 1-5
High Risk of Non-Melanoma Skin Cancer in Actinic Keratosis Patients with Skin of Color: A Nationwide Register-Based Cohort Study
Introduction: Actinic keratoses (AKs) are rough, scaly patches from UV exposure, increasing the risk of non-melanoma skin cancer (NMSC). This study examines AK incidence in Korea and its role as a risk factor for NMSC. Methods: A retrospective nationwide register-based cohort study analyzed 2,917 AK patients and 14,585 controls from 2002 to 2019. Patients diagnosed with AK were followed until NMSC occurrence, death, emigration, or December 2019. Results: AK incidence reached 44.8 per 100,000 person-years in 2019. The adjusted hazard ratio for NMSC in AK patients was 8.91 (95% confidence interval, 5.72–13.90). Higher NMSC risk was observed in female AK patients, those under 60 years, and those with lower income levels. The 16-year cumulative incidence of NMSC was 4.19% in AK patients versus 0.44% in controls. Conclusion: AK significantly increases the risk of NMSC in Koreans, highlighting the need for tailored surveillance and treatment strategies.
- 27 June 2024
- Published by S. Karger AG in Dermatology
- Vol. 240 (5-6) , 1-5
Open AccessHigh Risk of Non-Melanoma Skin Cancer in Actinic Keratosis Patients with Skin of Color: A Nationwide Register-Based Cohort Study
Introduction: Actinic keratoses (AKs) are rough, scaly patches from UV exposure, increasing the risk of non-melanoma skin cancer (NMSC). This study examines AK incidence in Korea and its role as a risk factor for NMSC. Methods: A retrospective nationwide register-based cohort study analyzed 2,917 AK patients and 14,585 controls from 2002 to 2019. Patients diagnosed with AK were followed until NMSC occurrence, death, emigration, or December 2019. Results: AK incidence reached 44.8 per 100,000 person-years in 2019. The adjusted hazard ratio for NMSC in AK patients was 8.91 (95% confidence interval, 5.72–13.90). Higher NMSC risk was observed in female AK patients, those under 60 years, and those with lower income levels. The 16-year cumulative incidence of NMSC was 4.19% in AK patients versus 0.44% in controls. Conclusion: AK significantly increases the risk of NMSC in Koreans, highlighting the need for tailored surveillance and treatment strategies.
- 19 March 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (9) , 1062-1064
The impact of appendectomy on the occurrence of alopecia areata: a retrospective cohort study
We explore the association between appendectomy and a higher risk of alopecia areata (AA). Analysing data from 16 385 people who had undergone appendectomy and a matched control group we found a higher incidence of AA in the appendectomy group, with a hazard ratio of 2.27 highlighted by the analysis. This suggests that appendectomy may affect the gut microbiome and immune regulation, having an impact on hair health and highlighting the role of appendectomy in autoimmune diseases.
- 19 March 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (9) , 1062-1064
The impact of appendectomy on the occurrence of alopecia areata: a retrospective cohort study
We explore the association between appendectomy and a higher risk of alopecia areata (AA). Analysing data from 16 385 people who had undergone appendectomy and a matched control group we found a higher incidence of AA in the appendectomy group, with a hazard ratio of 2.27 highlighted by the analysis. This suggests that appendectomy may affect the gut microbiome and immune regulation, having an impact on hair health and highlighting the role of appendectomy in autoimmune diseases.
- 21 February 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (9) , e772-e774
Associations between the tissue bacterial microbiome and keratinocyte cancer
- 21 February 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (9) , e772-e774
Associations between the tissue bacterial microbiome and keratinocyte cancer
- 17 February 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (4) , 532-538
Incidence and survival rates of primary cutaneous malignancies in Korea, 1999–2019: A nationwide population‐based study
Primary cutaneous malignancies are among the most commonly diagnosed types of cancer worldwide. We aimed to examine the incidence and 5‐year survival rates of all types of primary cutaneous malignancies in the Korean population. Data from the Korean Nationwide Cancer Registry from 1999 to 2019 were analyzed. The crude incidence rates, age‐standardized incidence rates, and 5‐year relative survival rates of each type of skin cancer were calculated. A total of 89 965 patients were diagnosed with primary cutaneous malignancies, which was a 7‐fold increase from 1999 to 2019. The age‐standardized incidence rates increased 3.4‐fold in basal cell carcinoma (3.7/100 000 person‐years), 2.0‐fold in squamous cell carcinoma (1.6/100 000 person‐years), 12.0‐fold in Bowen disease (1.2/100 000 person‐years), and 1.8‐fold in malignant melanoma (0.7/10 000 person‐years) in 2019. Average annual percentage changes in age‐standardized incidence rates were statistically significant in basal cell carcinoma (15.8%), Bowen disease (5.8%), squamous cell carcinoma (5.1%), malignant melanoma (1.2%), melanoma in situ (1.1%), dermatofibrosarcoma protuberans (1.2%), mycosis fungoides (0.5%), primary cutaneous CD30+ T‐cell proliferations (0.5%), adnexal and skin appendage carcinoma (0.4%), extramammary Paget's disease (0.2%), and Merkel cell carcinoma (0.2%). The 5‐year relative survival rates were the highest in basal cell carcinoma (103.3%), followed by dermatofibrosarcoma protuberans (99.7%) and mycosis fungoides (96.6%), and lowest in angiosarcoma (24.7%). The 5‐year relative survival rates steadily increased in extramammary Paget's disease (23.6%), cutaneous B‐cell lymphoma (21.3%), mycosis fungoides (20.2%), extranodal NK/T‐cell lymphoma, nasal type (18.1%), and malignant melanoma (16.1%) from 1996–2000 to 2015–2019. Most primary cutaneous malignancies have increased in incidence and survival rates in the Korean population, but to varying extents depending on the type of skin cancer.
- 17 February 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 51 (4) , 532-538
Incidence and survival rates of primary cutaneous malignancies in Korea, 1999–2019: A nationwide population‐based study
Primary cutaneous malignancies are among the most commonly diagnosed types of cancer worldwide. We aimed to examine the incidence and 5‐year survival rates of all types of primary cutaneous malignancies in the Korean population. Data from the Korean Nationwide Cancer Registry from 1999 to 2019 were analyzed. The crude incidence rates, age‐standardized incidence rates, and 5‐year relative survival rates of each type of skin cancer were calculated. A total of 89 965 patients were diagnosed with primary cutaneous malignancies, which was a 7‐fold increase from 1999 to 2019. The age‐standardized incidence rates increased 3.4‐fold in basal cell carcinoma (3.7/100 000 person‐years), 2.0‐fold in squamous cell carcinoma (1.6/100 000 person‐years), 12.0‐fold in Bowen disease (1.2/100 000 person‐years), and 1.8‐fold in malignant melanoma (0.7/10 000 person‐years) in 2019. Average annual percentage changes in age‐standardized incidence rates were statistically significant in basal cell carcinoma (15.8%), Bowen disease (5.8%), squamous cell carcinoma (5.1%), malignant melanoma (1.2%), melanoma in situ (1.1%), dermatofibrosarcoma protuberans (1.2%), mycosis fungoides (0.5%), primary cutaneous CD30+ T‐cell proliferations (0.5%), adnexal and skin appendage carcinoma (0.4%), extramammary Paget's disease (0.2%), and Merkel cell carcinoma (0.2%). The 5‐year relative survival rates were the highest in basal cell carcinoma (103.3%), followed by dermatofibrosarcoma protuberans (99.7%) and mycosis fungoides (96.6%), and lowest in angiosarcoma (24.7%). The 5‐year relative survival rates steadily increased in extramammary Paget's disease (23.6%), cutaneous B‐cell lymphoma (21.3%), mycosis fungoides (20.2%), extranodal NK/T‐cell lymphoma, nasal type (18.1%), and malignant melanoma (16.1%) from 1996–2000 to 2015–2019. Most primary cutaneous malignancies have increased in incidence and survival rates in the Korean population, but to varying extents depending on the type of skin cancer.
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (6) , 376-383
Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
Kim JE, et al. Ann Dermatol. 2024 Jun;36:e46. https://doi.org/10.5021/ad.24.033
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (6) , 376-383
Open AccessSurvey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
Kim JE, et al. Ann Dermatol. 2024 Jun;36:e46. https://doi.org/10.5021/ad.24.033
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (4) , 236-246
Korean Consensus Criteria for the Severity Classification of Alopecia Areata
Jang YH, et al. Ann Dermatol. 2024 Aug;36(4):236-246. https://doi.org/10.5021/ad.24.058
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (4) , 236-246
Open AccessKorean Consensus Criteria for the Severity Classification of Alopecia Areata
Jang YH, et al. Ann Dermatol. 2024 Aug;36(4):236-246. https://doi.org/10.5021/ad.24.058
- 21 November 2023
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (1) , 177-179
A novel nerve block technique for nail surgery
In pediatric patients, nail unit anesthesia is frequently required for procedures including matrixectomy or nail avulsion. However, nail unit anesthesia is very painful and requires a significant amount of time to take complete effect, causing a great deal of distress for most pediatric patients. By targeting the palmar and dorsal digital nerves in the distal part of the fingers, our method enables fast, simple, and less painful anesthesia.
- 21 November 2023
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (1) , 177-179
A novel nerve block technique for nail surgery
In pediatric patients, nail unit anesthesia is frequently required for procedures including matrixectomy or nail avulsion. However, nail unit anesthesia is very painful and requires a significant amount of time to take complete effect, causing a great deal of distress for most pediatric patients. By targeting the palmar and dorsal digital nerves in the distal part of the fingers, our method enables fast, simple, and less painful anesthesia.
- 1 November 2023
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 45 (11) , 748-752
Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi
Acral lentiginous melanoma (ALM) is a relatively rare clinicopathologic subtype of cutaneous malignant melanoma, but it is the most common type of melanoma among Asians. Although the research to identify immunohistochemical (IHC) markers to differentiate nevi from melanoma is being conducted, specific markers for ALM are not well-known. Therefore, we aimed to analyze and compare the differences in the expression of melanocyte-associated IHC markers between ALM and acral benign nevi (ABN). Two independent groups of 53 and 19 paraffin-embedded specimens (from patients with pathologically confirmed ALM and ABN, respectively) were subjected to IHC staining for MART-1, preferentially expressed antigen in melanoma (PRAME), SOX10, HMB-45, Ki-67, and p16. We performed a quantitative analysis of PRAME, SOX10, KI-67, and p16 expression and gradient pattern analysis of HMB-45 expression for each specimen. The PRAME (60.1% and 28.5%, P < 0.05) and Ki-67 (7.8% and 3.5%, P < 0.05) expression levels were significantly higher in the ALM group than in the ABN group. The p16 expression was significantly lower (14.2% and 19.4%, P < 0.05), and the absence of HMB-45 gradient was more frequent in the ALM group than in the ABN group. However, no statistical significance was noted in SOX10 (54.8% and 44.7%). Receiver operating characteristic curves showed that PRAME had the highest area under the curve value. In summary, among various IHC markers, PRAME was the most valuable marker for the diagnosis of ALM; however, further large-scale studies are needed to validate these findings.
- 1 November 2023
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 45 (11) , 748-752
Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi
Acral lentiginous melanoma (ALM) is a relatively rare clinicopathologic subtype of cutaneous malignant melanoma, but it is the most common type of melanoma among Asians. Although the research to identify immunohistochemical (IHC) markers to differentiate nevi from melanoma is being conducted, specific markers for ALM are not well-known. Therefore, we aimed to analyze and compare the differences in the expression of melanocyte-associated IHC markers between ALM and acral benign nevi (ABN). Two independent groups of 53 and 19 paraffin-embedded specimens (from patients with pathologically confirmed ALM and ABN, respectively) were subjected to IHC staining for MART-1, preferentially expressed antigen in melanoma (PRAME), SOX10, HMB-45, Ki-67, and p16. We performed a quantitative analysis of PRAME, SOX10, KI-67, and p16 expression and gradient pattern analysis of HMB-45 expression for each specimen. The PRAME (60.1% and 28.5%, P < 0.05) and Ki-67 (7.8% and 3.5%, P < 0.05) expression levels were significantly higher in the ALM group than in the ABN group. The p16 expression was significantly lower (14.2% and 19.4%, P < 0.05), and the absence of HMB-45 gradient was more frequent in the ALM group than in the ABN group. However, no statistical significance was noted in SOX10 (54.8% and 44.7%). Receiver operating characteristic curves showed that PRAME had the highest area under the curve value. In summary, among various IHC markers, PRAME was the most valuable marker for the diagnosis of ALM; however, further large-scale studies are needed to validate these findings.